Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases
Open Access
- 1 January 2006
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 77 (1), 66-70
- https://doi.org/10.1136/jnnp.2005.065441
Abstract
Background: Little is known about long term prognosis and course after immune treatments in chronic inflammatory demyelinating polyneuropathy (CIDP). Objective: To study long term outcomes and prognostic factors in patients with CIDP. Methods: Clinical and electrophysiological findings, responses to immune modulating treatments, and outcomes five years after the start of treatment were reviewed in 38 CIDP patients. Results: Patients were treated with corticosteroids (89%), immunoglobulin infusion (45%), or plasmapheresis (34%), and 58% received combined therapy. Five years after treatment was begun, 10 (26%) of the patients had complete remission (lasting >2 years with normal nerve conduction studies), and 23 (61%) had partial remission (able to walk) with (26%) or without (34%) immune treatments. The remaining five patients (13%) still had severe disability (unable to walk) or treatment dependent relapses. Patients with complete remission more often had subacute onset, symmetrical symptoms, good response to initial corticosteroid treatment, and nerve conduction abnormalities predominant in the distal nerve terminals. In contrast, insidious onset, asymmetrical symptoms, and electrophysiological evidence of demyelination in the intermediate nerve segments were associated with refractoriness to treatment or treatment dependent relapse. Conclusions: The long term prognosis of CIDP patients was generally favourable, but 39% of patients still required immune treatments and 13% had severe disabilities. Mode of onset, distribution of symptoms, and electrophysiological characteristics may be prognostic factors for predicting a favourable outcome.Keywords
This publication has 20 references indexed in Scilit:
- Onset and course of chronic inflammatory demyelinating polyneuropathyMuscle & Nerve, 2005
- Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathyJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Tumour necrosis factor-α has few morphological effects within the dorsal columns of the spinal cord, in contrast to its effects in the peripheral nervous systemJournal of Neuroimmunology, 2000
- A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathyAnnals of Neurology, 1994
- Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathyNeurology, 1993
- Multifocal motor neuropathy: Response to human immune globulinAnnals of Neurology, 1993
- Patterns of sensory nerve conduction abnormalities in demyelinating and axonal peripheral nerve disordersMuscle & Nerve, 1993
- Patterns and severity of conduction abnormalities in Guillain-Barre syndrome.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- A treatable multifocal motor neuropathy with antibodies to GM1 gangliosideAnnals of Neurology, 1988
- Topographical differences in the vascular permeability of the peripheral nervous systemActa Neuropathologica, 1968